Spina bifida cystica, commonly known as spina zonke in some African cultures, is a congenital condition characterized by an opening in the spine and protrusion of the meninges or spinal cord through this defect. This rare birth anomaly occurs when the neural tube fails to close during embryonic development.

The term “spina bifida” originates from Latin words for “split spine,” while “cystica” signifies a Spina Zonke cyst-like sac containing cerebrospinal fluid (CSF) and/or nerve tissue. Spina bifida cystica is one of several spina bifida conditions, including meningomyelocele and myelomeningocele.

Epidemiology

Spina bifida occurs in approximately 1/2,000 to 3,400 births worldwide, with varying prevalence rates across different regions. Males are more frequently affected than females (1.4:1). The condition has been consistently observed throughout history and remains a significant health concern for newborns.

Causes

Research indicates that multiple factors contribute to spina bifida development. These include:

• Genetic predisposition: Studies have shown an association between family history, genetic mutations, and the risk of developing spina bifida.
• Environmental influences:
  • Maternal nutrient deficiencies or excesses
  • Exposure to certain chemicals or pollutants
  • High fever during early pregnancy
• Biomechanical factors: The role of mechanical stress on fetal development is an area of ongoing research.

Symptoms

Manifestations of spina bifida cystica can vary in severity and presence. Key clinical features include:

1. Neurological impairment:
   • Spinal cord damage or compression
   • Loss of motor function, sensation, or reflexes
   • Impaired bladder or bowel control
2. Cerebrospinal fluid leakage:
3. Hydrocephalus (fluid accumulation in the skull): A potentially life-threatening complication requiring surgical intervention.

Diagnosis

A diagnosis typically involves:

1. Clinical assessment:
   • Physical examination to identify neurological deficits or abnormal reflexes
   • Imaging studies: ultrasonography, computed tomography scans, magnetic resonance imaging
2. Genetic screening:

Management and Treatment

Treatment for spina bifida cystica depends on the severity of symptoms, extent of spinal cord involvement, and presence of other complicating factors.

1. Surgical intervention:
   • Closure of the spinal defect to prevent CSF leakage and infection
   • Repair or removal of sacs containing meninges, nerve tissue, or fluid
2. Physical therapy and rehabilitation:
3. Ongoing care:

Prevention

Currently, no proven methods for completely preventing spina bifida cystica exist. However, research suggests that:

1. Folic acid supplementation during early pregnancy may reduce the risk.
2. Maternal nutrient adequacy is crucial for normal fetal development.

Conclusion

Spina bifida cystica (spina zonke) is a rare congenital condition characterized by an opening in the spine and protrusion of the meninges or spinal cord through this defect. Further research into causes, prevention strategies, and treatment options may contribute to improved patient outcomes.

The information provided here should not be considered comprehensive or definitive but rather serves as a general overview and introduction to spina bifida cystica.